Foam roller-based self-induced myofascial therapy in patients with hemophilic knee arthropathy: a multicenter, single-blind, randomized clinical study

Hemophilia is a congenital coagulopathy characterized by degenerative joint damage. Self-induced myofascial therapy aims to decrease pain and improve tissue mobility, functionality and proprioception. The aim of this study was to evaluate the safety and efficacy of self-induced myofascial release in...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of physical and rehabilitation medicine Vol. 59; no. 6; pp. 763 - 771
Main Authors Donoso-Úbeda, Elena, Pérez-Llanes, Raúl, Meroño-Gallut, Javier, Ucero-Lozano, Roberto, Cuesta-Barriuso, Rubén
Format Journal Article
LanguageEnglish
Published Italy Edizioni Minerva Medica 01.12.2023
Online AccessGet full text

Cover

Loading…
More Information
Summary:Hemophilia is a congenital coagulopathy characterized by degenerative joint damage. Self-induced myofascial therapy aims to decrease pain and improve tissue mobility, functionality and proprioception. The aim of this study was to evaluate the safety and efficacy of self-induced myofascial release in patients with hemophilic knee arthropathy. This is a randomized clinical study. This study was carried out in different patient associations. Fifty-two patients with hemophilia were included in the study. Patients were randomized to the experimental group (daily home protocol of foam roller-based self-induced myofascial therapy for 8 weeks) or the control group (no intervention). The variables were the frequency of hemarthrosis (self-reporting), pain intensity (visual analog scale), range of motion (goniometry) and muscle strength (dynamometry). All variables were evaluated at baseline, post-treatment and after a 10-week follow-up. The patients included in the experimental group showed significant improvements in terms of a decrease in frequency of hemarthrosis (mean difference [MD]=-0.61; 95% confidence interval [CI]: -0.81; -0.41) and pain intensity (MD=-0.33; 95% CI: -0.48, -0.18), increased range of motion (MD=0.88; 95% CI: 0.39; 1.37), strength in quadriceps (MD=0.88; 95% CI: 0.39; 1.37). (MD=12.39; 95% CI: 3.44; 21.34) and hamstrings (MD=7.85; 95% CI: 0.60; 15.11). There were intergroup differences in the frequency of hemarthrosis (F=14.51; P<0.001), pain intensity (F=9.14; P<0.001) and range of motion (F=13.58; P<0.001). Self-induced myofascial therapy can be an effective complementary technique in the treatment of patients with hemophilic arthropathy. Self-induced myofascial therapy can reduce the frequency of knee hemarthrosis in patients with hemophilia. This technique can improve pain intensity and range of motion in patients with hemophilic knee arthropathy. Hemophilic knee arthropathy is characterized by chronic pain, decreased range of motion, and periarticular muscle atrophy. Foam roller-based self-induced myofascial therapy can reduce the frequency of hemarthrosis and pain intensity and improve range of motion in patients with hemophilic arthropathy. Foam roller-based self-induced myofascial therapy is safe and effective in the treatment of patients with hemophilia. The inclusion of self-induced myofascial therapy exercises in the approach to degenerative joint pathologies may be an effective and safe treatment option.
Bibliography:Authors’ contributions: Elena Donoso-Úbeda, Raúl Pérez-Llanes, Javier Meroño-Gallut, Roberto Ucero-Lozano and Rubén Cuesta-Barriuso contributed equally to the manuscript, Elena Donoso-Úbeda, Javier Meroño-Gallut, Roberto Ucero-Lozano and Rubén Cuesta-Barriuso have given substantial contributions to study conception and design, Roberto Ucero-Lozano and Rubén Cuesta-Barriuso to data acquisition, analysis and interpretation, Elena Donoso-Úbeda, Raúl Pérez-Llanes, Javier Meroño-Gallut, Roberto Ucero-Lozano and Rubén Cuesta-Barriuso to manuscript writing, Elena Donoso-Úbeda to manuscript critical revision. All authors read and approved the final version of the manuscript.
ISSN:1973-9087
1973-9095
DOI:10.23736/S1973-9087.23.07944-3